Atlas Trials

A Study of Radiation Therapy and Cemiplimab With or Without Fianlimab In People With Bladder Cancer

Clinical trial NCT07414992 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07414992
Sponsor
Memorial Sloan Kettering Cancer Center
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Bladder Urothelial Carcinoma
Start date
2026-09-01
Primary completion
2028-03-01
Enrollment
44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.